RUNX1 DNA-binding mutations and RUNX1-PRDM16 cryptic fusions in BCR-ABL+ leukemias are frequently associated with secondary trisomy 21 and may contribute to clonal evolution and imatinib resistance. (Q44661684)
Jump to navigation
Jump to search
scientific article published on 17 January 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | RUNX1 DNA-binding mutations and RUNX1-PRDM16 cryptic fusions in BCR-ABL+ leukemias are frequently associated with secondary trisomy 21 and may contribute to clonal evolution and imatinib resistance. |
scientific article published on 17 January 2008 |
Statements
RUNX1 DNA-binding mutations and RUNX1-PRDM16 cryptic fusions in BCR-ABL+ leukemias are frequently associated with secondary trisomy 21 and may contribute to clonal evolution and imatinib resistance (English)
Sami Joha
Sélim Corm
Jean-Luc Laï
Isabelle Tigaud
Franck-Emmanuel Nicolini
Fi-LMC group
Lauréline Deluche
Nathalie Philippe